An illustration of the potential for mapping MRI/MRS parameters with genetic
over-expression profiles in human prostate cancer.
Lenkinski RE, Bloch BN, Liu F, Frangioni JV, Perner S, Rubin MA, Genega EM,
Rofsky NM, Gaston SM.
MAGMA. 2008 Aug 28. Epub ahead of print
Prostate cancer: accurate determination of extracapsular extension with
high-spatial-resolution dynamic contrast-enhanced and T2-weighted MR
imaging--initial results.
Bloch BN, Furman-Haran E, Helbich TH, Lenkinski RE, Degani H, Kratzik C, Susani
M, Haitel A, Jaromi S, Ngo L, Rofsky NM.
Radiology. 2007 Oct;245(1):176-85. Epub 2007 Aug 23.
Prostate postbrachytherapy seed distribution: comparison of high-resolution,
contrast-enhanced, T1- and T2-weighted endorectal magnetic resonance imaging
versus computed tomography: initial experience.
Bloch BN, Lenkinski RE, Helbich TH, Ngo L, Oismueller R, Jaromi S, Kubin K,
Hawliczek R, Kaplan ID, Rofsky NM.
Int J Radiat Oncol Biol Phys. 2007 Sep 1;69(1):70-8. Epub 2007 May 21.
Tissue-print and print-phoresis as platform technologies for the molecular
analysis of human surgical specimens: mapping tumor invasion of the prostate
capsule.
Gaston SM, Soares MA, Siddiqui MM, Vu D, Lee JM, Goldner DL, Brice MJ, Shih JC,
Upton MP, Perides G, Baptista J, Lavin PT, Bloch BN, Genega EM, Rubin MA,
Lenkinski RE.
Nature Medicine 2005 Jan;11(1):95-101. Epub 2004 Dec 26.
3 Tesla magnetic resonance imaging of the prostate with combined pelvic
phased-array and endorectal coils; Initial experience(1).
Bloch BN, Rofsky NM, Baroni RH, Marquis RP, Pedrosa I, Lenkinski RE.
Acad Radiol. 2004 Aug;11(8):863-7.
